Can chronic obstructive lung disease (COPD) criteria be used to manage bronchiectasis (BR) and obliterative bronchiolitis (OB) in children surviving severe lung infection? Source: Eur Respir J 2001; 18: Suppl. 33, 172s Year: 2001
The metabolic syndrome (MetS) in patients with chronic obstructive pulmonary disease (COPD) and its association with airway obstruction Source: Annual Congress 2012 - COPD is not a pulmonary disease alone Year: 2012
Differential therapy of acute respiratory failure (ARF) in chronic obstructive pulmonary disease (COPD) patients with predominance of emphysema (PE) and predominance of bronchitis (PB) Source: Eur Respir J 2006; 28: Suppl. 50, 395s Year: 2006
Asthma-COPD overlap syndrome (ACOS) Source: Respipedia Article Year: 2017
FVC/slow VC (FVC/SVC) as a marker for small airways obstruction, evaluated in bronchiolitis obliterans syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 686s Year: 2005
Disease of the airways in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 41S-49S Year: 2001
Definition and differential diagnosis of chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=1 Year: 2006
Pulmonary function and clinical outcome of patients with post-infectious bronchiolitis obliterans (BO) Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome Year: 2007
Small airway inflammation in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 501s Year: 2001
Chronic obstructive pulmonary disease (COPD) and metabolic syndrome (MS) Source: Eur Respir J 2006; 28: Suppl. 50, 249s Year: 2006
Vocal cord dysfunction (VCD) in hospitalised exacerbations of asthma and chronic obstructive pulmonary disease (COPD). Source: International Congress 2019 – Person-centred approaches to COPD and asthma care Year: 2019
The effect of dipyrone on respiratory function in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 290s Year: 2004
Community-acquired pneumonia (CAP): differences between patients with chronic obstructive pulmonary disease (COPD) and those without COPD Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020
Benefits of pulmonary rehabilitation (PR) in patients with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) having the same dyspnoea severity Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? Year: 2018
Chronic obstructive pulmonary disease (COPD) patients with bronchiectasis: clinical features? Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018
Pulmonary rehabilitation (PR) outcomes in chronic obstructive pulmonary disease (COPD) compared with interstitial lung disease (ILD) Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD Year: 2011
Bronchiectasis impact outcomes in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008
Platelets activation during chronic obstructive pulmonary disease (COPD) exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 89s Year: 2002
Microbiological features of the indicators of bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD) during remission Source: International Congress 2019 – Clinical aspects of airway diseases Year: 2019
Reversibility of airflow limitation in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 587s Year: 2004